A study showed that GHK-Cu increased skin collagen density by 28% on average over three months
Semaglutide revs weight loss by mimicking GLP-1, a hormone your body makes to regulate appetite, blood sugar, and digestion
Across all trials, 10,442 participants (44.2%) were female, participants mean HbA 1c at baseline was 66.6 mmol/mol (8.3%), mean body weight was 88.8 kg and mean age was 57.8 years (Table 1)
Sample 1-Day Keto-GLP-1 Meal Plan (Small, Nutrient-Dense Meals) Early in a GLP-1 drug, when hunger is at its lowest and every meal has to punch above its weight, this is about what I would draw out for a customer
What are the absolute and relative contraindications to GLP-1/GIP agonist therapy
The patient must: Be age 18 or older Have eligible Medicare Part D coverage Be prescribed treatment specifically for weight reduction and maintenance Participate in ongoing nutrition and physical activity intervention Not have already received a GLP-1 through their Part D plan Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction The patient must also have met one of these criteria when GLP-1 therapy was originally started: BMI 35 BMI 30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+ BMI 27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease Important: Eligibility is based on BMI at treatment initiation, not necessarily the patients current BMI
